Beta-Hydroxybutyrate LiquiColor® assay


BHB-reagent-banner

Key features


  • Quantitative accuracy for early detection and monitoring of ketosis
  • Diagnostic grade precision, sensitivity, and monitoring tool
  • FDA -Cleared Method
  • Industry Leading Performance
  • Made in the United States

Inquire now

BHB LiquiColor® Assay is a quantitative, quick, and simple test for ketosis


The Stanbi Chemistry LiquiColor® Beta-Hydroxybutyrate (B-HB) reagent is a vital tool for detecting ketones and monitoring patient resolution in cases of diabetic ketoacidosis. Its quantitative nature enables precise monitoring of ketosis trends and clinical status in patients, extending its utility beyond DKA to conditions such as alcoholism, glycogen storage disease, and more.

 

Trusted by over 1,100 hospitals across the USA, our Beta-Hydroxybutyrate reagent is renowned for its reliability and accuracy. Its compatibility with open-channel chemistry laboratory analyzers makes it the preferred choice for healthcare professionals. 

 

With its broad clinical applications and widespread adoption, our B-HB reagent stands out as the superior ketone test in hospital settings and among distributors. Partner with us to elevate your ketone testing capabilities and enhance patient care.

 

stanbio

Beta-Hydroxybutyrate specifications


Beta-Hydroxybutyrate LiquiColor®

Methodology Key Features Contents Reference No.
Beta-Hydroxybutyrate Dehydrogenase / INT Ready-to-use liquid reagents
Linear up to 8.0 mmol/L
Read @ 505 nm 

R1: 1 x 50 mL

R2: 1 x 8.5 mL

STD: 1 x 3 mL (1 mmol/L)

2440-058

Beta-Hydroxybutyrate LiquiColor® Test (Beckman Synchron CX/LX/DX)

Methodology Key Features Contents Reference No.
Beta-Hydroxybutyrate Dehydrogenase / INT

Linear up to 8.0 mmol/L

Read @ 520 nm

2 x 90 tests

B2440-180

Watch the video


Why testing for diabetic ketoacidosis?


People with type 1 diabetes may be at risk when they do not have enough insulin, a hormone the body uses to break down sugar (glucose) in the blood for energy. When the body senses glucose is not available, fat is broken down instead.

As fats are broken down, acids called ketones build up in the blood and urine. Ketones are poisonous in high levels. This condition is called ketoacidosis.

Blood glucose levels rise (usually higher than 200 mg/dL) because the liver makes glucose to try to combat the problem. However the cells cannot pull in that glucose without insulin.

Symptoms can include rapid deep breathing, dry skin and mouth, flushed face, fruity smelling breath, nausea, vomiting and stomach pain.

Other symptoms that can occur are; abdominal pain, breathing difficulty while lying down, decreased appetite, decreased consciousness, muscle stiffness and aches, dulled senses that may worsen to a coma and frequent urination and thirst that lasts for a day or more.

 

Why is Beta-Hydroxybutyrate the best test for ketoacidosis diagnosis?


When the body begins to break down its stored fats in response to a low supply of energy (glucose) it produces the ketone Beta-Hydroxybutyrate (B-HB), which is further catabolised into acetoacetate and then into acetone.

Ketones (like glucose) can be tested or monitored in either urine or blood. Many hospitals still use the nitroprusside method for confirming  ketoacidosis. The nitroprusside urine method is efficient at providing  qualitative assessment of ketosis and ketoacidosis by detecting both acetoacetate and acetone. However, nitroprusside methods do not detect Beta-Hydroxybutyrate.

 

B-HB is a better test for ketosis and ketoacidosis than nitroprusside methods for a number of reasons:

  1. Beta-Hydroxybutyrate demonstrates excellent stability, making it the most reliable indicator of clinically relevant ketosis and ketoacidosis.
  2. During ketosis, Beta-Hydroxybutyrate levels increase more than levels of acetone and acetoacetate, clearly indicating the patient's trend in metabolic status.
  3. Quantitative, objective Beta-Hydroxybutyrate results provide a better tool for differentiating metabolic acidosis and monitoring therapy.

beta-hydroxybutyrate-Diabetic-Ketoacidosis

EKF-Ketosis-Guide.jpg

A guide to ketosis and B-HB

The detection of ketosis is important in several clinical conditions. The most important is the detection of potentially fatal ketoacidosis in diabetics. 

These fats are metabolized in the liver and this metabolism produces chemical byproducts called ketones. The buildup of ketones can prove fatal a condition known as acidosis.

 

 

Read our full guide

 

Beta-Hydroxybutyrate supporting information


Metabolic Disturbances that Lead to B-HB and Ketone Bodies

 

videoHolder-Metabolic-Disturbances-Lead-Beta-Hydroxybutyrate-Ketone.jpg

James. H Nichols, PhD, DABCC, FACB
Pathology Grand Rounds at mid-west medical school

Beta-Hydroxybutyrate – Uses in the ICU Especially in the Setting of DKA

 

videoHolder-Beta-Hydroxybutyrate-Setting-DKA.jpg

Mark. H Oltermann MD
JPS Physician Group, John Peter Smith Hospital, Fort Worth, Texas

The Value Efficacy and Efficiency of Beta-Hydroxybutyrate

 

videoHolder-Efficacy-Efficiency-Beta-Hydroxybutyrate.jpg

James. H Nichols, PhD, DABCC, FACB
The 2012 Clinical Lab Expo in Los Angeles

References


  1. Savage MW, Dhatariya KK, Kilvert A, Rayman G, Rees JA, Courtney CH, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. May 2011;28(5):508-15. [Medline].
  2. Joint British Diabetes Societies Inpatient Care Group. The Management of Diabetic Ketoacidosis in Adults. March 2010. Available at http://www.diabetes.nhs.uk/document.php?o=1336 Accessed June 27, 2011.
  3.  Wallace TM, Matthews DR. Recent advances in the monitoring and management of diabetic ketoacidosis. QJM. Dec 2004;97(12):773-80. [Medline].
  4. Timmons JA, Myer P, Maturen A, et al. Use of beta-hydroxybutyric acid levels in the emergency department. Am J Ther. May 1998;5(3):159-63. [Medline].
  5. Taboulet P, Haas L, Porcher R, et al: Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department setting. Eur J Emerg Med 2004; 11(5):251-258.
  6. Carragher FM, Bonham JR, & Smith JM: Pitfalls in the measurement of some intermediary metabolites.. Ann Clin Biochem 2003; 40(4):313-320.
  7. Arora S, Henderson SO, Long T, Menchine M. Diagnostic Accuracy of Point-of- Care Testing for Diabetic Ketoacidosis at Emergency-Department Triage: {beta}-Hydroxybutyrate versus the urine dipstick. Diabetes Care. Apr 2011;34(4):852-4. [Medline]. [Full Text].
  8. Arora S, Henderson SO, Long T, Menchine M. Diagnostic Accuracy of Point-of- Care Testing for Diabetic Ketoacidosis at Emergency-Department Triage: {beta}-Hydroxybutyrate versus the urine dipstick. Diabetes Care. Apr 2011;34(4):852-4. [Medline]. [Full Text].
  9. Menchine M, Probst MA, Agy C, Bach D, Arora S. Diagnostic accuracy of venousblood gas electrolytes for identifying diabetic ketoacidosis in the emergency department. Acad Emerg Med. 20 Oct;18(10):1105-8. doi: 10.1111/j.1553-2712.2011.01158.x. Epub 2011 Sep 26. PubMed PMID: 21951652.
  10. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):412- 26. Review. PubMed PMID: 10634967.
  11. Lone SW, Siddiqui EU, Muhammed F, Atta I, Ibrahim MN, Raza J. Frequency, clinical characteristics and outcome of diabetic ketoacidosis in children with type-1 diabetes at a tertiary care hospital. J Pak Med Assoc. 2010 Sep;60(9):725-9. PubMed PMID: 21381577.
  12. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM. Tests of glycemia in diabetes Technical review, Diabetes Care. 1995;18(6):896-909.